-
2024-513682-40-01
5
2025-07-04
Non-squamous (NSQ), Stage IV or Recurrent Non-small Cell Lung Cancer
-
2024-518469-84-00
4
2025-06-20
Colorectal cancer
-
2024-517458-90-00
5
2025-06-06
Chronic obstructive pulmonary disease (COPD)
-
2023-509547-27-00
5
2025-05-22
Geographic Atrophy Secondary to Age-Related Macular Degeneration
-
2024-515526-89-00
4
2025-05-16
Diffuse Large B-Cell Lymphoma (DLBCL)
-
2024-513862-20-00
5
2025-03-26
Chronic Rhinosinusitis with Nasal Polyposis
-
2023-510292-65-00
5
2025-02-25
chronic graft-versus-host disease
-
2023-505245-13-00
6
2025-02-12
Chronic obstructive pulmonary disease (COPD)
-
2023-505320-54-00
4
2025-01-30
Multiple System Atrophy
-
2023-508813-18-00
4
2024-12-18
Refractory Focal Onset Epilepsy
-
2023-508817-18-00
5
2024-10-08
Perennial Allergic Rhinitis (PAR)
-
2023-507064-39-00
5
2024-09-26
generalized Myasthenia Gravis
-
2023-508811-21-00
10
2024-09-25
Refractory Focal Onset Epilepsy
-
2023-508520-36-00
5
2024-09-06
Seasonal allergic rhinitis/rhinoconjunctivitis induced by grass pollen
-
2023-503705-10-00
6
2024-08-19
Dementia in Pick disease
-
2023-507407-59-00
5
2024-07-04
Chronic Obstructive Pulmonary Disease (COPD)
-
2024-515267-59-00
4
2024-04-07
Acute myeloid leukemia
-
2023-503376-24-00
5
2024-03-20
Metastatic non-small cell lung cancer (NSCLC)
-
2022-502282-24-00
5
2024-02-14
Primary generalized tonic-clonic seizures
-
2024-511537-35-00
9
2024-02-09
Metastatic castration-resistant prostate cancer (mCRPC)
-
2024-516634-35-00
6
2024-02-01
Convulsive or nonconvulsive benzodiazepine-resistant (established) sta
-
2023-506971-89-00
5
2024-01-25
Coronary Artery Disease
-
2024-512881-32-00
6
2023-11-22
Psoriasis vulgaris and/or psoriatric arthritis
-
2022-503133-54-00
7
2023-08-09
Solid Tumors